Ertapenem is a carbapenem used to treat a wide range of bacterial infections. What sets ertapenem apart from other carbapenems is its longer half-life which implies it need only be administered once daily. We developed a physiologically-based pharmacokinetic model for the distribution of ertapenem within the body. In the model, parameters such as human body weight and height, age, organ volumes, blood flow rates, and partition coefficients of particular tissues are used to examine the absorption, distribution, metabolism, and excretion of ertapenem. The total and free blood concentrations found were then compared to experimental data. We then examined the sensitivity of the total concentration in the blood to body weight, body height, and a...
Ertapenem, a carbapenem, relies on time-dependent killing. Therapeutic drug monitoring (TDM) should ...
Objectives: The objective of this study was to determine the pharmacokineticspharmacodynamics (PK/PD...
Ertapenem, a Group 1 carbapenem, is a once-a-day parenteral β-lactam antibiotic recently licensed in...
Ertapenem is an antibiotic commonly used to treat a broad spectrum of infections, which is part of a...
Previous research suggests that the efficacy of Ertapenem, a carbapenem antibiotic administered intr...
Ertapenem is an antibiotic commonly used to treat a broad spectrum of infections and is part of a br...
Vancomycin is an antibiotic used for the treatment of systemic infections. It is given intravenously...
This study characterizes the pharmacokinetics of ertapenem, a carbapenem antibiotic, in critically i...
Ertapenem is a carbapenem antibiotic with activity against Mycobacterium tuberculosis. Dose simulati...
Ertapenem is a broad-spectrum carbapenem antibiotic whose activity against Mycobacterium tuberculosi...
Background: Ertapenem is a therapeutic option in patients with Gram-negative bone and joint infectio...
Background. The objective of this study was to determine the pharmacokinetics-pharmacodynamics (PK/P...
OBJECTIVE: To describe the pharmacokinetics of and the exposure to ertapenem in chronic haemodialysi...
Treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is bec...
Levofloxacin is in a class of antibiotics known as fluoroquinolones, which treat infections by killi...
Ertapenem, a carbapenem, relies on time-dependent killing. Therapeutic drug monitoring (TDM) should ...
Objectives: The objective of this study was to determine the pharmacokineticspharmacodynamics (PK/PD...
Ertapenem, a Group 1 carbapenem, is a once-a-day parenteral β-lactam antibiotic recently licensed in...
Ertapenem is an antibiotic commonly used to treat a broad spectrum of infections, which is part of a...
Previous research suggests that the efficacy of Ertapenem, a carbapenem antibiotic administered intr...
Ertapenem is an antibiotic commonly used to treat a broad spectrum of infections and is part of a br...
Vancomycin is an antibiotic used for the treatment of systemic infections. It is given intravenously...
This study characterizes the pharmacokinetics of ertapenem, a carbapenem antibiotic, in critically i...
Ertapenem is a carbapenem antibiotic with activity against Mycobacterium tuberculosis. Dose simulati...
Ertapenem is a broad-spectrum carbapenem antibiotic whose activity against Mycobacterium tuberculosi...
Background: Ertapenem is a therapeutic option in patients with Gram-negative bone and joint infectio...
Background. The objective of this study was to determine the pharmacokinetics-pharmacodynamics (PK/P...
OBJECTIVE: To describe the pharmacokinetics of and the exposure to ertapenem in chronic haemodialysi...
Treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is bec...
Levofloxacin is in a class of antibiotics known as fluoroquinolones, which treat infections by killi...
Ertapenem, a carbapenem, relies on time-dependent killing. Therapeutic drug monitoring (TDM) should ...
Objectives: The objective of this study was to determine the pharmacokineticspharmacodynamics (PK/PD...
Ertapenem, a Group 1 carbapenem, is a once-a-day parenteral β-lactam antibiotic recently licensed in...